Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hypnosis may ease ventilator weaning in ICU

NCT ID NCT07518498

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a short hypnosis session can help patients in the intensive care unit (ICU) wean off a breathing machine. Researchers will try hypnosis on 30 adults who have been on a ventilator for at least 48 hours and are ready to start breathing on their own. The goal is to see if hypnosis is feasible and whether it reduces pain and anxiety during the process.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
hypnosis session
What this could lead to
If it works, hypnosis could become a drug-free way to help ICU patients breathe on their own sooner, reducing side effects from sedatives.
What could go wrong
This is a very small feasibility study (30 people) that only checks if hypnosis is possible during weaning, not whether it actually works. Results may not apply to all ICU patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 and older * Patients hospitalized in the intensive care unit and requiring invasive mechanical ventilation for at least 48 hours * Presence of the prerequisite criteria for ventilator weaning: effective cough, minimal bronchial congestion, patient awake and not agitated, hemodynamic stability (heart rate less than 140 beats per minute, systolic blood pressure between 90 and 160 mmHg without vasopressors), pressure support ventilation, FiO2 \< 40% and PEEP ≤ 8 cmH2O, PaO2/FiO2 \> 150, pH \> 7.35, respiratory rate \< 35 per minute * Patients enrolled in a social security program or eligible for such a program * Patients who has received complete information about the clinical research protocol and has signed an informed consent form * Patients who has undergone a preliminary clinical examination appropriate for the clinical research Exclusion Criteria: * Contraindication to hypnosis (particularly severe psychotic disorders) * Non-French-speaking individuals * Deaf or hard-of-hearing individuals * State of agitation or acute delirium * Individuals who have already undergone a spontaneous ventilation test or an attempt at orotracheal extubation during their hospitalization * Individuals receiving a new anxiolytic or sedative treatment within 2 hours prior to the weaning test * Individuals with a tracheostomy * Women of childbearing age who do not have access to effective contraception * Individuals covered by Articles L. 1121-5, L. 1121-7, and L. 1121-8 of the Public Health Code (pregnant women, women in labor, or breastfeeding women, minors not emancipated, adult subject to a legal protection measure, adult unable to give consent) * Person deprived of liberty by a judicial or administrative decision, or a person receiving psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypnosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Central Hospital

    Nancy, 54000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.